drugset / Trial / NCT00498745
Study Comparing 2 New Formulations of HKI-272 in Healthy Adult Subjects
RandomizedCrossoverOpen-label
Summary
To evaluate the comparative bioavailability of 2 new tablet formulations of HKI-272 with a reference capsule and an oral solution in healthy subjects.
Timeline
- Start
- 2007-07
- Primary completion
- —
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neratinib | Small molecule | 240 mg | Oral |
Indications
No indication recorded.